Practical Considerations for Next-Generation Adjuvant Development and Translation

WR Lykins, CB Fox - Pharmaceutics, 2023 - mdpi.com
Over the last several years, there has been increased interest from academia and the
pharmaceutical/biotech industry in the development of vaccine adjuvants for new and …

Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations

B Lee, E Nanishi, O Levy, DJ Dowling - Pharmaceutics, 2023 - mdpi.com
Infection persists as one of the leading global causes of morbidity and mortality, with
particular burden at the extremes of age and in populations who are immunocompromised …

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine

C Bissett, S Belij-Rammerstorfer, M Ulaszewska… - npj Vaccines, 2024 - nature.com
Although licensed vaccines against influenza virus have been successful in reducing
pathogen-mediated disease, they have been less effective at preventing viral infection of the …

DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's disease

KP Daily, A Badr, M Eltobgy, S Estfanous… - Alzheimer's Research & …, 2024 - Springer
Alzheimer's disease (AD) is the sixth leading cause of death in the USA. It is established that
neuroinflammation contributes to the synaptic loss, neuronal death, and symptomatic …

[HTML][HTML] Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial …

JM Hall, JL Gutierrez-Ferman, MM Shamseldin, M Guo… - bioRxiv, 2024 - ncbi.nlm.nih.gov
Despite global vaccination, pertussis caused by Bordetella pertussis (Bp) is resurging.
Pertussis resurgence is correlated with the switch from whole cell vaccines (wPV) that elicit …

Use of Mucosally Administered Outer Membrane Vesicles Derived from Bordetella pertussis to Diminish Nasal Bacterial Colonization

E Rudi, ME Gaillard, D Bottero, D Hozbor - bioRxiv, 2024 - biorxiv.org
Background: We previously identified Bordetella pertussis-derived outer membrane vesicles
(OMVs) as a promising immunogen for improving pertussis vaccines. In this study, we …